KMPharmaceutical Co Ltd

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

8.42%

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Yil Mo Kang

Co-Chief Executive Officer, Director · since 2023

Seung Won Baik

Co-Chief Executive Officer, Director · since 2023

URL

IPO date

Oct 08, 2015

Employees

Domiciled in

Incorporated in

No data to show